Skip to main content
. 2016 Jan 27;18(4):549–556. doi: 10.1093/neuonc/nov326

Fig. 1.

Fig. 1.

Consort chart. Surgery and EOR prior to study entry in the DIRECTOR trial. Arm A (1 wk on [120 mg/m2 per day]/1 wk off TMZ); arm B (3 wk on [80 mg/m2 per day]/1 wk off TMZ). Black: patients who did not undergo surgery; white: patients with CRET; light gray: patients with incomplete resection.